Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Beuzeboc

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[What's new in 2009 in prostate cancer: highlights from ASTRO, EAU, ASCO and AUA meetings]L Salomon, M Peyromaure, P Mongiat-Artus, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2013
[Prostate brachytherapy: indications and outcomes]C Hennequin, L Cormier, P Richaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 14, 2014
[Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of Urology)]L Cormier, C Bastide, P Beuzeboc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancerJ L Misset, V Dieras, G Gruia, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 18, 2015
[Imagery of treated prostate cancer]R Renard-Penna, L Michaud, L Cormier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 11, 2020
[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020]F Rozet, C Hennequin, P Beuzeboc, et al.
British Journal of Cancer|November 15, 2000
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancerJ Y Pierga, E Mouret, V Diéras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2011
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trialA Fléchon, D Pouessel, C Ferlay, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 16, 2009
[Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience]Y M Kirova, Z Bourhaleb, S Alran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 25, 2010
[What's new in 2009 in prostate cancer: highlights from ASTRO, EAU, ASCO and AUA meetings]L Salomon, M Peyromaure, P Mongiat-Artus, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 1, 2013
[Prostate brachytherapy: indications and outcomes]C Hennequin, L Cormier, P Richaud, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|May 14, 2014
[Prostate cancer surgical margin: review by the CCAFU (Oncology Committee of the French Association of Urology)]L Cormier, C Bastide, P Beuzeboc, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancerJ L Misset, V Dieras, G Gruia, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 18, 2015
[Imagery of treated prostate cancer]R Renard-Penna, L Michaud, L Cormier, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 11, 2020
[French CCAFU guidelines on prostate cancer: hormone-sensitive metastatic prostate cancer-update 2020]F Rozet, C Hennequin, P Beuzeboc, et al.
British Journal of Cancer|November 15, 2000
Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancerJ Y Pierga, E Mouret, V Diéras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2011
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trialA Fléchon, D Pouessel, C Ferlay, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|June 16, 2009
[Preoperative concomitant radiochemotherapy in bulky carcinoma of the cervix: Institut Curie experience]Y M Kirova, Z Bourhaleb, S Alran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Multicentre phase II study of oxaliplatin as a single-agent in cisplatin/carboplatin +/- taxane-pretreated ovarian cancer patientsV Dieras, P Bougnoux, T Petit, et al.
Pageof 14